Cardenalin and fall Patient Reports February 12, 2012

Cardenalin Side Effects Report #4971617-0
Cardenalin side effect was reported by a Physician from JAPAN on Mar 31, 2006. Female patient, 68 years of age, weighting 99.87 lb, was diagnosed with hypertension, depression , cerebral circulatory failure, hyperlipidaemia and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood pressure diastolic decreased, blood pressure systolic decreased, cervical myelopathy, depressed level of consciousness, depression , faeces hard, fall , haemorrhage. Cardenalin dosage: 2 MG (BID); ORAL. During the same period patient was treated with AMLODIPINE, FLUVOXAMINE MALEATE, NICERGOLINE, ENALAPRIL MALEATE, SIMVASTATIN, LECICARBON, AMBROXOL HYDROCHLORIDE, ALDIOXA. Patient was hospitalized. Patient recovered.

Cardenalin Side Effects Report #5104049-5
Cardenalin side effect was reported by a Pharmacist from JAPAN on Aug 30, 2006. Male patient, 52 years of age, was diagnosed with hypertension and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: fall , subarachnoid haemorrhage. Cardenalin dosage: 4 MG (1 IN 1 D), ORAL. During the same period patient was treated with LOSARTAN POTASSIUM. Patient recovered.

Cardenalin Side Effects Report #4643119-2
Cardenalin side effect was reported by a Physician from on Apr 11, 2005. Male patient, 70 years of age, weighting 133.2 lb, was diagnosed with essential hypertension, cerebral infarction and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: alcohol use, cerebral infarction, concomitant disease progression, disease recurrence, fall , hyperosmolar state, hypoglycaemia, hypotension. Cardenalin dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with OLMESARTAN MEDOXOMIL, CILOSTAZOL, STARLIX, VOGLIBOSE, CHOUTOUSAN, GOSYZAINIGAN. Patient was hospitalized and became disabled. Patient recovered.

Cardenalin Side Effects Report #4650034-7
Cardenalin side effect was reported by a Physician from on Apr 19, 2005. Male patient, 70 years of age, weighting 133.2 lb, was diagnosed with essential hypertension, cerebral infarction and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: alcohol use, cerebral infarction, concomitant disease progression, disease recurrence, dizziness , fall , fatigue, hyperosmolar state, hypoglycaemia. Cardenalin dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with OLMESARTAN MEDOXOMIL, CILOSTAZOL, STARLIX, VOGLIBOSE, CHOUTOUSAN, GOSYAZINKIGAN. Patient was hospitalized and became disabled. Patient recovered.


Cardenalin Side Effects Report #4666275-9
Cardenalin side effect was reported by a Physician from on May 09, 2005. Male patient, 70 years of age, weighting 133.2 lb, was diagnosed with essential hypertension, cerebral infarction and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: alcohol use, cerebral infarction, disease progression, disease recurrence, dizziness , expressive language disorder, fall , fatigue, hemiparesis. Cardenalin dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with OLMETEC, PLETAL, NATEGLINIDE, BASEN, CHOUTOUSAN, GOSYAZINKIGAN. Patient was hospitalized and became disabled. Patient recovered.

Cardenalin Side Effects Report #4692188-2
Cardenalin side effect was reported by a Physician from on June 03, 2005. Male patient, 70 years of age, weighting 133.2 lb, was diagnosed with essential hypertension, cerebral infarction and was treated with Cardenalin. After drug was administered, patient experienced the following side effects: cerebral infarction, disease progression, dizziness , expressive language disorder, fall , fatigue, hemiparesis, hyperosmolar state, hypoglycaemia. Cardenalin dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with OLMETEC, PLETAL, NATEGLINIDE, BASEN, CHOUTOUSAN, GOSYAZINKIGAN. Patient was hospitalized and became disabled. Patient recovered.